The findings stem from a recent meeting of a WHO Guideline Development Group convened to address challenges with TB diagnosis and related drug-resistance.
The Guardian reports that visas for some members of the World Health Organization team investigating the origins of SAR-CoV-2 have not yet been approved by China.